Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/2333
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChavda, Mukesh M.-
dc.contributor.authorSolanki, Manish J.-
dc.contributor.authorUpadhyay, Jatin-
dc.date.accessioned2011-06-28T08:15:35Z-
dc.date.available2011-06-28T08:15:35Z-
dc.date.issued2011-02-
dc.identifier.issn0976-1209-
dc.identifier.urihttp://hdl.handle.net/123456789/2333-
dc.descriptionInternational Journal of Chemical and Analytical Science, Vol. 2 (2), February, 2011, Page No. 15-17en_US
dc.description.abstractA series of new N-(2,5-dimethylphenyl)-7-methyl/7-methyl -3-oxo-5-phenyl-2,3-dihydro-5H-[1,3]thiazolo[3,2-a] pyrimidine-6-carboxamide have been synthesized by a three component (MCR) reaction involving N-(2,5-dimethylphenyl)-3-oxobutanamide,thioura and substituted benzaldehyde gives N-(2,5- dimethylphenyl)-6-methyl-4-phenyl-2-sulfanyl-1,2,3,4-tetrahydro pyrimidine-5-carboxamide which on reaction with dibromoethane /chloro acetylchloride respectively. The newly synthesized compounds were well characterized by elemental analysis, IR, 1H NMR and mass spectral studies. The newly synthesized compounds were screened for their antibacterial and antifungal activities and have exhibited moderate to excellent growth inhibition of bacteria and fungi. The results of such studies have been discussed in this paper.en_US
dc.publisherVIJCASen_US
dc.relation.ispartofseriesIDFCH011-4en_US
dc.subjectN-(2,5-dimethylphenyl)-3-oxobutanamideen_US
dc.subjectThiazolo[3,2-a]pyrimidinne-6-carboxamideen_US
dc.subjectAntimicrobial Activityen_US
dc.subjectChemical Faculty Paperen_US
dc.subjectFaculty Paperen_US
dc.subjectIDFCH011en_US
dc.titleSynthesis and Antimicrobial Activity of Novel Pyrazolo [3,4-d] Pyrimidine Derivativesen_US
dc.typeFaculty Papersen_US
Appears in Collections:Faculty Papers, Chemical - IDs

Files in This Item:
File Description SizeFormat 
IDFCH011-4.pdfIDFCH011-446.95 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.